RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Somerset, NJ · +139 more sites
Obesity clinical trials in Somerset, NJ
4 recruiting obesity studies with a site in Somerset, NJ.
RecruitingPhase 3NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Somerset, NJ · +22 more sites
RecruitingPhase 3NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Sponsor: AstraZeneca
Eatontown, NJ · Somerset, NJ · Warren Township, NJ · +51 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Bridgewater, NJ · Marlton, NJ · Newark, NJ · +118 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.